Rituximab in the treatment of diffuse large B-Cell lymphomas

被引：41
作者：
Coiffier, B
机构：
[1] Hospices Civils Lyon, Lyon, France
[2] Univ Lyon 1, F-69365 Lyon, France
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期
关键词：
D O I：
10.1053/sonc.2002.30153
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：30 / 35
页数：6
相关论文
共 30 条
  • [1] Chan WC, 1997, BLOOD, V89, P3909
  • [2] Chan WC, 1997, ANN ONCOL, V8, P973
  • [3] COIFFIER B, 1994, ANN ONCOL, V5, P873
  • [4] Coiffier B, 1998, BLOOD, V92, P1927
  • [5] Coiffier B, 2000, BLOOD, V96, p223A
  • [6] Coiffier B, 1997, TXB MED ONCOLOGY, P265
  • [7] Czuczman MS, 1999, SEMIN ONCOL, V26, P88
  • [8] Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs
    Demidem, A
    Lam, T
    Alas, S
    Hariharan, K
    Hanna, N
    Bonavida, B
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1997, 12 (03) : 177 - 186
  • [9] COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA
    FISHER, RI
    GAYNOR, ER
    DAHLBERG, S
    OKEN, MM
    GROGAN, TM
    MIZE, EM
    GLICK, JH
    COLTMAN, CA
    MILLER, TP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) : 1002 - 1006
  • [10] Grillo-López AJ, 1999, SEMIN ONCOL, V26, P66
123